Now showing items 1-4 of 4
Quality use of medicines for palliative care
(Cancer Council Australia, 2007-03)
Many of the drugs commonly used in palliative care are not listed on the Pharmaceutical Benefits Scheme in Australia and are therefore not freely available to patients outside the acute hospital system. In an attempt to ...
Defining refractory pain in cancer for clinicians and researchers
(Mary Ann Liebert, Inc., 2012-01-23)
Managing pain in people with cancer remains a challenge, especially in those referred to as having refractory pain. But what is refractory or intractable pain? Until there is a standard definition there is the risk that: ...
Planning phase III multi-site clinical trials in palliative care: the role of consecutive cohort audits to identify potential participant populations
Goals of Work: Multiple sites enable more successful completion of adequately powered phase III studies in palliative care. Audits of the frequency and distribution of the symptoms of interest can better inform research ...
Progressing an evidence-base beyond case series
(Mary Ann Liebert, Inc., 2011-12-06)
High-quality randomized trials in hospice and palliative care are achievable to provide quality evidence to guide our practice especially if several sites work together to conduct the trial. Palliative medicine is a specialty ...